In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul

Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 108.9% to $2.03 during Monday's reg

PARIS, July 30, 2026 (GLOBE NEWSWIRE) -- In accordance with articles L.233-8 II of the French Commer

Nanobiotix is rated a strong speculative Buy, driven by risk-adjusted upside from its JNJ-1900 radio

Nanobiotix is evolving into a capital-light, milestone- and royalty-driven oncology platform with JN

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul

Leerink Partners analyst Jonathan Chang maintains Nanobiotix (NASDAQ:NBTX) with a Outperform and

Completed a follow-on offering in May 2026 for aggregate gross proceeds of approximately €86.1 milli

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: N

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic app

PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: N

PARIS and CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

PARIS and CAMBRIDGE, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

PARIS, France and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NA

PARIS and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

PARIS and CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NB

Nanobiotix wants to fundamentally change a century-old mainstay in battling cancer. The top-notch bi

U.S. stock futures lower with Nasdaq down 200 points. XP Inc (XP) falls after reporting lower-than-e

Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial

Data presented by Johnson & Johnson at the 2026 European Society for Radiotherapy and Oncology (ESTR

PARIS and CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) --  NANOBIOTIX (Euronext: NANO –– NASDAQ:

Shares of Nanobiotix S.A. - Sponsored ADR (NASDAQ: NBTX - Get Free Report) have been given a consens

Preclinical evaluation in mice assessed the potential of the Nanobiotix Nanoprimer to overcome commo

Preclinical evaluation in mice assessed the potential of the Nanobiotix Nanoprimer to overcome commo

Nanobiotix (NASDAQ: NBTX - Get Free Report) and NRx Pharmaceuticals (NASDAQ: NRXP - Get Free Report)

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regul

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the p

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 62.82 percent inc

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 137.18 percent de

U.S. stock futures down, Zenas Biopharma shares fall 9.5% in pre-market trading due to pricing of pu

Nanobiotix rejects takeover talk after J&J speculation; stock jumps as analysts weigh momentum s

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic app

U.S. stocks higher as Dow Jones gains 300 points; El Pollo LoCo Holdings jumps 17.6% on better-than-

U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-

Guggenheim analyst Michael Schmidt maintains Nanobiotix (NASDAQ:NBTX) with a Buy and raises the p

$71 million in funding would extend Nanobiotix cash visibility into early 2028Transaction enables Na